Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
about
[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.Radiomics analysis of pre-treatment [F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatmentPredicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
P2860
Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@ast
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@en
type
label
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@ast
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@en
prefLabel
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@ast
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@en
P2093
P2860
P1433
P1476
Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis
@en
P2093
Eun-Kyu Kim
Ho-Young Lee
Ji-In Bang
Sohyun Park
P2860
P2888
P356
10.1038/S41598-017-01524-7
P407
P50
P577
2017-05-08T00:00:00Z
P6179
1085208556